By Ben Hirschler LONDON (Reuters) - Europe's medicines regulator has endorsed a scheme to publish detailed clinical reports underpinning new drug approvals from next year, though campaigners for full transparency said they were concerned some data would still be missing. The London-based European Medicines Agency (EMA) has been at the center of a row about divulging trials data for the past two years, following concerns over undisclosed data for certain drugs such as Roche's flu pill Tamiflu. ...
via Health News Headlines - Yahoo News http://ift.tt/1rApfJ4
via Health News Headlines - Yahoo News http://ift.tt/1rApfJ4
No comments:
Post a Comment